Viewing Study NCT05449366

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-24 @ 4:33 PM
Ignite Modification Date: 2026-02-23 @ 1:11 AM
Study NCT ID: NCT05449366
Status: COMPLETED
Last Update Posted: 2025-09-02
First Post: 2022-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False
Brief Title: Intraperitoneal Paclitaxel for Patients With Primary Malignant Peritoneal Mesothelioma
Sponsor: Erasmus Medical Center
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Peritoneal Malignant Mesothelioma View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Intraperitoneal chemotherapy View
None Paclitaxel View
None Systemic chemotherapy View
None Palliative treatment View
None Dose-escalation study View